Aarey Drugs & Pharmaceuticals Ltd.
BSE: 524412 | Sector: Health care |
NSE: AAREYDRUGS | ISIN Code: INE198H01019 |
BSE 11:18 | 11 Aug | 34.80 |
-0.30 (-0.85%) |
OPEN
35.25 |
HIGH
35.25 |
LOW
34.80 |
NSE 11:04 | 11 Aug | 35.05 |
-0.10 (-0.28%) |
OPEN
35.15 |
HIGH
36.20 |
LOW
34.75 |
OPEN | 35.25 |
PREVIOUS CLOSE | 35.10 |
VOLUME | 630 |
52-Week high | 64.40 |
52-Week low | 28.50 |
P/E | 13.49 |
Mkt Cap.(Rs cr) | 88 |
Buy Price | 34.80 |
Buy Qty | 198.00 |
Sell Price | 35.15 |
Sell Qty | 10.00 |
Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) - Net Profit
Net Profit
COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Profit (Rs crore) |
Cipla | 1041.50 | 3.30 | 0.32 | 2957.93 |
Divi's Lab. | 3928.60 | -17.05 | -0.43 | 2948.54 |
Glaxosmi. Pharma | 1447.40 | 2.40 | 0.17 | 1690.53 |
Glenmark Pharma. | 371.90 | -3.80 | -1.01 | 1649.45 |
Dr Reddy's Labs | 4264.55 | 22.15 | 0.52 | 1623.20 |
Alkem Lab | 2975.15 | 17.60 | 0.60 | 1541.25 |
Aurobindo Pharma | 570.75 | 6.50 | 1.15 | 1454.71 |
Gland Pharma | 2327.60 | 20.30 | 0.88 | 1212.16 |
Alembic Pharma | 652.70 | 0.35 | 0.05 | 1175.39 |
Torrent Pharma. | 1541.10 | 0.20 | 0.01 | 991.45 |
Sanofi India | 6415.75 | 0.70 | 0.01 | 944.40 |
Ipca Labs. | 1020.00 | 28.15 | 2.84 | 870.94 |
Zydus Lifesci. | 368.70 | 4.05 | 1.11 | 857.90 |
Abbott India | 19394.15 | -214.05 | -1.09 | 798.70 |
Laurus Labs | 565.20 | 6.50 | 1.16 | 750.09 |
Ajanta Pharma | 1273.35 | 0.75 | 0.06 | 719.86 |
Apollo Hospitals | 4460.80 | -58.25 | -1.29 | 665.20 |
Pfizer | 4175.00 | 5.55 | 0.13 | 612.56 |
Piramal Enterp. | 1926.10 | 105.35 | 5.79 | 572.28 |
Suven Pharma | 446.20 | 7.25 | 1.65 | 558.10 |
Quick Links for Aarey Drugs & Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices